Qingsi Geometry Medical Anti-Hair Loss and Hair Regrowth Center successfully opened in Beijing, tapping into the new blue ocean market of scalp health

On January 10, Cordis Group, a leading domestic dermatological pharmaceuticals publicly listed company, and Beijing Jingcheng Skin Hospital Group, a well-known publicly listed medical services provider, combined their respective advantages in pharmaceuticals and clinical resources to jointly establish the first professional medical hair loss prevention and hair regrowth institution — Qing Si Ji He Clinic flagship store, which grandly opened at Beijing Jingcheng Skin Hospital. At the opening ceremony, numerous senior dermatology and trichology experts were present to witness the launch of this new platform focused on professional hair health services.

Mr. Hu Yi, Vice President of Beijing Jingcheng Skin Hospital Group and CEO of Jingcheng Bio, stated: 'Nowadays, scalp hair loss is increasingly becoming a major concern for the public, with the group of hair consumers continuously growing, transitioning from 'hair care' to 'medical treatment.' As a professional skin medical institution that has been deeply involved in China’s dermatological clinical field for 20 years, Beijing Jingcheng Skin Hospital Group has joined hands with Cordis Group, a renowned and leading domestic dermatological pharmaceuticals publicly listed company,to leverage their combined strengths to develop and deliver a series of professionally validated medical solutions for hair maintenance, hair loss prevention, hair regrowth, and hair transplantation.。”

Regarding this service system, Mr. Sun Chao, President of Cordis Group's commercial platform, explained its core model: 'Qing Si Ji He hopesto provide precise testing and etiological analysis so that every patient can clearly understand the cause of their hair loss and receive personalized hair regrowth treatment plans, complemented by professional anti-hair loss products,forming a closed-loop service of 'diagnosis-solution-products.' This model aimsto precisely fill the current market gap where there is an overemphasis on products and insufficient attention to diagnosis and treatment,enhancing the scientific rigor and specificity of hair loss treatments.'

This innovative model has received high recognition from clinical experts.Song Peihua, an expert from the China-Japan Friendship Hospital, commented in an interview: 'The establishment of the Qing Si Geometry Medical Anti-Hair Loss and Hair Regrowth Center provides a new paradigm for hair health diagnosis and treatment.'

The scalp health industry is currently experiencing explosive growth. The phenomenon of 'early hair loss' has created a vast market demand, with consumers’ attention to scalp issues evolving from basic cleaning and dandruff control to an urgent need for refined, efficacy-driven solutions such as 'anti-hair loss and hair regrowth, oil control and volume enhancement, and scalp anti-aging.' Consumers are in dire need of solutions that offer both medical professional endorsement for effectiveness and convenient, systematic services.Qing Si Geometry is precisely aligned with this trend, leveraging 'pharmaceutical research + clinical validation' as its core competitiveness to tap into the rapidly growing blue ocean market of scalp health.。

The 'Qing Si Geometry' brand focuses on three core areas: anti-hair loss and hair regrowth, scalp anti-aging, and hair aesthetics. It belongs to the dual-listed enterprise ecosystem of Cordis Group and Beijing Skin Hospital Group, and is an innovative brand dedicated to scalp health and hair medicine, adhering to pharmaceutical-grade and clinical research and development standards. Relying on Cordis Group's profound R&D strength and technological innovation in the professional hair and skin fields, its research achievements have been verified through tens of thousands of experiments, providing a solid guarantee for the safety and efficacy of its products. Meanwhile, Beijing Skin Hospital, a well-known tertiary specialized skin hospital in China, offers a strong clinical platform and authoritative medical support.